68 results
Page 3 of 4
DEF 14A
05t 2r9gt
22 Nov 21
Definitive proxy
4:37pm
S-1
7msr6l
12 Nov 21
IPO registration
5:03pm
8-K
EX-10.1
xjdmq
15 Oct 21
Petros Pharmaceuticals Announces $5.7 Million Registered Direct Offering
5:03pm
424B5
l7teq81l599 dhsun
15 Oct 21
Prospectus supplement for primary offering
5:01pm
10-Q
szfnzb qj13
14 May 21
Quarterly report
4:31pm
10-K
EX-10.1
yfq0eb8exc9n nm1
31 Mar 21
Annual report
4:30pm
10-K
wxe ck1ob6dnh
31 Mar 21
Annual report
4:30pm
8-K
EX-10.2
e39g4i zt
25 Feb 21
Departure of Directors or Certain Officers
4:15pm
S-3
tsh 7k63c
29 Jan 21
Shelf registration
4:48pm
S-8
EX-23.2
0g61r08
22 Jan 21
Registration of securities for employees
4:15pm
S-8
EX-5.1
p0g06myjonk8v
22 Jan 21
Registration of securities for employees
4:15pm
S-8
25yzrabsjt8i678pxw
22 Jan 21
Registration of securities for employees
4:15pm
8-K/A
EX-99.1
ks9081 ioulkhdo25y
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
8-K
EX-10.1
mwzo3ubo31qboc26 2si
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
8-K
o2hwbd86z75f2v22d
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
8-K
EX-3.2
ftng7c xn8afefzuotzd
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
424B3
ipst src3rs6
2 Nov 20
Prospectus supplement
12:00am